Esperite N.V.: Update to the market on the publication of the Annual Report 2018
Esperite N.V. (ESP): Update to the market on the publication of the Annual Report 2018
Amsterdam, The Netherlands – 28 June 2019
Esperite N.V. announced on 30 April 2019 that the publication of the Annual Report 2018 will be delayed. The Company made significant progress was confident in its ability to publish the Annual Report 2018 and Half Year Results 2018 before the end of June 2019. Despite the entire dedication of the company’s finance team, Esperite has to announce further delays and hope to be able to publish its annual report before July 7th 2019.
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - firstname.lastname@example.org or visit the websites at www.esperite.com, www.genoma.com and www.cryo-save.com.
Upcoming Life Sciences Events
- September 2019
- Boston: 9th Annual American Drug Delivery & Formulation Summit
- Malmo: NLS Days 2019
- Boston: Redefining Early Stage Investments (RESI)
Latest company news
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute